FDA accepts Sanofi's new diabetes drug application

05:39 AM | July 7, 2014 | Natasha Alperowicz

Sanofi (Paris) said today that the US FDA has accepted for review the company's new drug application for Toujeo, an investigational basal insulin. This follows the acceptance of the marketing...